ALPHA TEKNOVA, INC. Gain (Loss) on Extinguishment of Debt
ALPHA TEKNOVA, INC. (TKNO) reported Gain (Loss) on Extinguishment of Debt of $0 for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-07.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:GainsLossesOnExtinguishmentOfDebt · last filed 2025-03-07
- ALPHA TEKNOVA, INC. gain (loss) on extinguishment of debt for the quarter ending 2024-12-31 was $0.00.
- ALPHA TEKNOVA, INC. gain (loss) on extinguishment of debt for the quarter ending 2024-09-30 was $0.00.
- ALPHA TEKNOVA, INC. gain (loss) on extinguishment of debt for the quarter ending 2023-12-31 was $0.00.
- ALPHA TEKNOVA, INC. gain (loss) on extinguishment of debt for the quarter ending 2023-09-30 was -$824.00K.
- ALPHA TEKNOVA, INC. gain (loss) on extinguishment of debt for fiscal 2024 was $0.00.
- ALPHA TEKNOVA, INC. gain (loss) on extinguishment of debt for fiscal 2023 was -$824.00K.
- ALPHA TEKNOVA, INC. gain (loss) on extinguishment of debt for fiscal 2022 was $0.00.
| Period end | Gain (Loss) on Extinguishment of Debt 3 month | Gain (Loss) on Extinguishment of Debt 6 month | Gain (Loss) on Extinguishment of Debt 9 month | Gain (Loss) on Extinguishment of Debt 12 month |
|---|---|---|---|---|
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-07 | $0.00 derived: sum of 2 quarters · filed 2025-03-07 | $0.00 10-K · filed 2025-03-07 | |
| 2024-09-30 | $0.00 10-Q · filed 2024-11-08 | $0.00 10-Q · filed 2024-11-08 | ||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-07 | -$824.00K derived: sum of 2 quarters · filed 2025-03-07 | -$824.00K 10-K · filed 2025-03-07 | |
| 2023-09-30 | -$824.00K 10-Q · filed 2024-11-08 | -$824.00K 10-Q · filed 2024-11-08 | ||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-27 | $0.00 derived: sum of 2 quarters · filed 2024-03-27 | $0.00 10-K · filed 2024-03-27 | |
| 2022-09-30 | $0.00 10-Q · filed 2023-11-13 | $0.00 10-Q · filed 2023-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |